Eastern Coast of Central America Commercial and Agricultural Company

Alliance feature ends lint issues

Retrieved on: 
Wednesday, November 1, 2023
Alliance Laundry Systems, Senior, Environment, HVAC, Tumbler, Eastern Coast of Central America Commercial and Agricultural Company, Maintenance, Dry cleaning

RIPON, Wis., Nov. 1, 2023 /PRNewswire/ -- Alliance Laundry Systems, the global leader in commercial laundry equipment, announces the introduction of a revolutionary dryer feature that eliminates the problems caused by lint.

Key Points: 
  • RIPON, Wis., Nov. 1, 2023 /PRNewswire/ -- Alliance Laundry Systems, the global leader in commercial laundry equipment, announces the introduction of a revolutionary dryer feature that eliminates the problems caused by lint.
  • ProCapture uses patent-pending cyclone technology to capture 98 percent* of dryer lint – a significant increase over the lint screens used in most commercial tumble dryers.
  • As anyone in the laundry industry knows, lint causes a number of issues for operations," said Craig Dakauskas, Senior Vice President, Americas Commercial, Alliance Laundry Systems.
  • With this industry-first feature, Alliance will drive improved tumbler performance, reduce staff time spent cleaning lint compartments, and reduce maintenance costs – all benefits that deliver real dollars in savings.

Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program

Retrieved on: 
Wednesday, October 25, 2023
Philanthropy, Mental Health, Health, Other Philanthropy, General Health, Pharmaceutical, Biotechnology, National Association, Partnership, Mental, Education, NYSE, Direct Relief, Eastern Coast of Central America Commercial and Agricultural Company, Create, Senior counsel, Cape May Court House, New Jersey, Reconciliation (United States Congress), Canadian Mental Health Association, Food, Doctor of Philosophy, ACE, Trauma, TEVA, SDOH, COVID, Curriculum, Transport, University, Health equity, Pharmacy, NAFC, Teva Pharmaceuticals, TASE, House, Language, Depression, National Association of Free and Charitable Clinics, People's Commissariat of Communication Routes of the Soviet Union, Anxiety, Disability, Patient, Red Bank, Parent, Mental health, Pharmaceutical industry, Hospital, Nursing, Teva, Medicine

The second round of funding to the clinics in Florida, New Jersey and California underscores the commitment by Teva and its partners to expand access to mental health resources.

Key Points: 
  • The second round of funding to the clinics in Florida, New Jersey and California underscores the commitment by Teva and its partners to expand access to mental health resources.
  • “Over the past year, free clinics serving the most vulnerable patients were able to use these resources as a force multiplier for good.
  • "Through this partnership, we are able to help address the rising need for community-based mental health care for uninsured and underserved populations."
  • Nicole Lamoureux, President and CEO of NAFC said, “It is imperative that we continue to prioritize investment into mental health and behavioral programs.

Teva Announces Changes to Executive Management Team

Retrieved on: 
Thursday, September 28, 2023
Biotechnology, Pharmaceutical, Health, Amgen, Bone, TEVA, Marketing, Novartis Gene Therapies, Nephrology, Novartis, TASE, Merck, NYSE, Eastern Coast of Central America Commercial and Agricultural Company, Management, Teva, Takeda

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team.

Key Points: 
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team.
  • “On behalf of the Teva Board of Directors and our executive management team, I want to thank Sven for his many contributions to Teva during his 15 years with the company,” said Richard Francis, Teva’s President, and Chief Executive Officer, “I am pleased to announce the appointment of Chris Fox to this critical role.
  • Chris is a heralded pharmaceutical executive with extensive experience growing and overseeing complex business units and regional operations throughout the world.
  • I have every confidence that Chris will bring great strength to Teva and be pivotal to our success.”
    Christine (Chris) Fox comes to Teva as Executive Vice President, U.S. Commercial Business from her role at Novartis Gene Therapies where she started as President in December 2021.

GOODYEAR HAS BEEN HONORING HEROIC TRUCK DRIVERS ON THE ROADS FOR 40 YEARS

Retrieved on: 
Thursday, September 14, 2023
Driver's licenses in the United States, CDL, Travel, Life, Website, GT, TMC, 125th, Exhibition, Driven, Knowledge, Growth, Goodyear Tire and Rubber Company, Commercial, Courage, Eastern Coast of Central America Commercial and Agricultural Company, Heavy equipment, Road transport

AKRON, Ohio, Sept. 14, 2023 /PRNewswire/ -- In celebration of National Truck Driver Appreciation Week and the 40th year of the Goodyear Highway Hero Award, The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced the call for entries for the 2023 Highway Hero Award. Since 1983 Goodyear has been recognizing commercial truck drivers who go above and beyond their regular duties to keep our highways safe. 

Key Points: 
  • Since 1983 Goodyear has been recognizing commercial truck drivers who go above and beyond their regular duties to keep our highways safe.
  • Nearly every aspect of our daily lives is made possible thanks to a commercial truck driver," said Dave Beasley, vice president, North America Commercial.
  • To commemorate this historic year, Goodyear will select two winners from a wider pool of commercial drivers than ever before.
  • The Goodyear Highway Hero Award is one way Goodyear helps recognize the growth and importance of the commercial trucking industry.

ELEVATE CELEBRATES CONTINUED GROWTH AND EXPANSION FOLLOWING REBRAND

Retrieved on: 
Wednesday, August 30, 2023
Holcim, Investment, TPO, EPDM, Eastern Coast of Central America Commercial and Agricultural Company, Plant, Acquisition, Growth, Knowledge, SA, Safety, Polymer, Retail, Renewable energy, Elevate

NASHVILLE, Tenn., Aug. 30, 2023 /PRNewswire/ -- Elevate™, the premier provider of commercial roofing, wall and lining systems, is thriving and growing after its acquisition by Holcim and subsequent rebrand in June 2022. Through plant improvements, new manufacturing locations, capital investments, vertical integration and supply chain improvements, Elevate continues to expand its offerings while upholding the legacy Firestone brand's commitment to the highest standards in the industry.

Key Points: 
  • "This is an exciting growth period as we invest in the brand and leverage synergies across the Holcim Building Envelope portfolio."
  • Since the acquisition, Elevate has grown through strategic investment in operational improvements, increasing manufacturing capacity, and establishing new locations.
  • Growth and improvement strategies extend beyond plant expansion and product innovation.
  • Our vision is to make a difference in the world, with sustainability at the core of everything we do."

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Retrieved on: 
Monday, July 24, 2023
Partnership, TEVA, Teva, Food and Drug Administration, Adalimumab, TEL, Patient, TASE, Biosimilar, FDA, Ustekinumab, NYSE, Food, Eastern Coast of Central America Commercial and Agricultural Company, Generic drug

Teva will also acquire subordinated convertible bonds to be issued by Alvotech.

Key Points: 
  • Teva will also acquire subordinated convertible bonds to be issued by Alvotech.
  • The expansion to the existing strategic partnership agreement pertains to exclusive commercialization in the U.S. by Teva of two new biosimilar candidates and line extensions of two current biosimilar candidates in the partnership, to be developed, and manufactured by Alvotech.
  • Teva and Alvotech will share profit from the commercialization of the biosimilars.
  • “We welcome Teva’s continued partnership and this expansion of our partnership agreement,” said Robert Wessman, Chairman and CEO of Alvotech.

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Retrieved on: 
Monday, July 24, 2023
Health, FDA, Other Health, General Health, Pharmaceutical, Biotechnology, Partnership, TEVA, Teva, Food and Drug Administration, Adalimumab, Medication, Patient, TASE, Biosimilar, Ustekinumab, NYSE, Food, Eastern Coast of Central America Commercial and Agricultural Company, Generic drug

Teva will also acquire subordinated convertible bonds to be issued by Alvotech.

Key Points: 
  • Teva will also acquire subordinated convertible bonds to be issued by Alvotech.
  • The expansion to the existing strategic partnership agreement pertains to exclusive commercialization in the U.S. by Teva of two new biosimilar candidates and line extensions of two current biosimilar candidates in the partnership, to be developed, and manufactured by Alvotech.
  • Teva and Alvotech will share profit from the commercialization of the biosimilars.
  • “We welcome Teva’s continued partnership and this expansion of our partnership agreement,” said Robert Wessman, Chairman and CEO of Alvotech.

Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer

Retrieved on: 
Monday, July 10, 2023
Epilepsy, United States Navy, Medicine, University, Marketing, Chief commercial officer, Clinical trial, MBA, Brain, Kellogg School, Economics, Thought, Dasyphyllum diacanthoides, Organization, Route, Thrombectomy, Patient, SAN, Health, Growth, Northwestern University, LivaNova, Eastern Coast of Central America Commercial and Agricultural Company, Stroke

SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Chris Hartman to the role of Chief Commercial Officer.

Key Points: 
  • SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Chris Hartman to the role of Chief Commercial Officer.
  • In this role, Chris will be responsible for continuing to build the sales and marketing organizations to grow Route 92 Medical’s global commercial footprint.
  • “Route 92 Medical has developed remarkable technologies which offer the potential to dramatically improve outcomes for patients who have endovascular procedures in the brain, starting with a game-changing therapy for ischemic stroke,” said Chris Hartman, Chief Commercial Officer at Route 92 Medical.
  • “Chris has been remarkably successful in facilitating commercial growth in the neurovascular space and other medical technology categories,” said Tony Chou, CEO of Route 92 Medical.

Alliance Laundry Systems Distribution Expands West Region with Acquisition

Retrieved on: 
Monday, June 26, 2023
Pacific Northwest, Senior, History, Eastern Coast of Central America Commercial and Agricultural Company, Alliance Laundry Systems, Speed Queen, Airline, Dynamics

RIPON, Wis., June 26, 2023 /PRNewswire/ -- Alliance Laundry Systems, the global leader in commercial laundry equipment, acquired the distribution assets of Kirkland, Wash.-based Dynamic Sales and Service.

Key Points: 
  • RIPON, Wis., June 26, 2023 /PRNewswire/ -- Alliance Laundry Systems, the global leader in commercial laundry equipment, acquired the distribution assets of Kirkland, Wash.-based Dynamic Sales and Service.
  • "We remain committed to partnering with distributors who have a long history of excellent service," said Craig Dakauskas, Senior Vice President, Americas Commercial, Alliance Laundry Systems.
  • "Dynamic definitely fits that criteria and we are excited to bring them into Alliance Laundry Systems Distribution."
  • Dynamic will become part of the Alliance Laundry Systems Distribution West Region, while maintaining its Kirkland, Wash. office.

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

Retrieved on: 
Monday, June 12, 2023
Biotechnology, Pharmaceutical, Health, Partnership, TEVA, Teva, Doctor of Philosophy, JNJ, Patient, TASE, Johnson & Johnson, Ustekinumab, NYSE, Eastern Coast of Central America Commercial and Agricultural Company, Generic drug

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced they have reached a settlement and license agreement with Johnson & Johnson (NYSE:JNJ) concerning AVT04, Alvotech’s proposed biosimilar to Stelara® (ustekinumab) in the United States.

Key Points: 
  • Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced they have reached a settlement and license agreement with Johnson & Johnson (NYSE:JNJ) concerning AVT04, Alvotech’s proposed biosimilar to Stelara® (ustekinumab) in the United States.
  • The settlement grants a license entry date for AVT04 in the United States no later than February 21, 2025.
  • “We are delighted to have secured a U.S. license date for our second biosimilar candidate in the U.S. and I believe this exemplifies our multi-product approach to biosimilars globally,” said Robert Wessman, Chairman and CEO of Alvotech.
  • “Biosimilars are a key component of Teva’s short and long-term strategy,” said Sven Dethlefs, PhD, Executive Vice President, North America Commercial at Teva, “Today’s announcement is another step forward in our partnership with Alvotech, who shares our commitment to lower the cost burden of biologics on the healthcare system.”